Stocktoria

biote Corp. BTMD

Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 2021-03-02

biote Corp. statistics & valuation

Market cap$67.3M
P / E2.5×
P / S0.3×
P / FCF2.2×
Dividend yield2.57%
Net margin14.1%
FCF margin15.7%
Net debt$79.0M
Net debt / EBITDA2×
Enterprise value USD$146.3M
EV / EBITDA3.7×
Earnings yield EBIT/EV24.3%
Return on capital56.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
8.00% -0.60% 1.80% 1.60% 14.10% 20212022202320242025
Gross margin (%)
20212022202320242025
Operating margin (%)
24.80% -36.80% 15.50% 16.00% 18.50% 20212022202320242025
Return on equity (%)
269.40% 20212022202320242025
Shares outstanding
58.2M 25.7M 34.3M 36.7M 20212022202320242025
Net debt ($)
$31.8M $42.6M $26.6M $70.0M $79.0M 20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
20.50% -0.90% 2.10% 2.60% 25.10% 20212022202320242025
Free cash flow margin (%)
23.20% -5.80% 14.30% 19.70% 15.70% 20212022202320242025
Debt / equity (×)
7.75× 20212022202320242025
EPS ($)
-$0.12 $0.13 $0.09 $0.74 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Operating margin18.5%16.0%15.5%-36.8%24.8%
Net margin14.1%1.6%1.8%-0.6%8.0%
FCF margin15.7%19.7%14.3%-5.8%23.2%
Return on assets25.1%2.6%2.1%-0.9%20.5%
Return on equity-46.2%-3.0%-9.1%1.7%269.4%
Debt / equity-1.76×-1.03×-3.16×-2.09×7.75×
Current ratio1.221.325.515.392.72

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.